{"disease":{"id":"kahler-disease","name":"kahler disease"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT04782687","title":"Study of Selinexor Plus DRd for Newly Diagnosed Multiple Myeloma","phase":"PHASE2","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":73,"lead_sponsor_name":"US Oncology Research","has_results":false},{"nct_id":"NCT02057640","title":"MLN9708 (Ixazomib) in Combination With Panobinostat and Dexamethasone in Multiple Myeloma","phase":"PHASE1, PHASE2","overall_status":"COMPLETED","enrollment_count":16,"lead_sponsor_name":"Jason Valent","has_results":true}],"total":2},"guidelines":[],"source":"Drug Landscape verified database"}